U.S. Food and Drug Administration

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species

WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved Solensia (frunevetmab injection), the first treatment for the control of pain associated with osteoarthritis in cats and the first …

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species Read More


coronavirus